Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Sáenz López, Pablo ^a   Carretero, Rafael ^a   Cózar, José Manuel ^a   Romero, José Maria ^a   Canton, Julia ^a   Vilchez, José Ramon ^a   Tallada, Miguel ^a   Garrido, Federico ^a   Ruiz Cabello, Francisco ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CYTOSINE; GLYCINE; INTERLEUKIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; THREONINE; TUMOR NECROSIS FACTOR ALPHA; CCL2 PROTEIN, HUMAN; CCL5 PROTEIN, HUMAN; IL1A PROTEIN, HUMAN; TNF PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA POLYMORPHISM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PROMOTER REGION; PROSTATE TUMOR; RISK FACTOR;

AGED; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CHEMOKINE CCL5; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-1ALPHA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 60549113573     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-382     Document Type: Article

References (57)

1. Coussens LM Werb Z Inflammation and cancer Nature 2002, 420:860-867. 10.1038/nature01322 12490959
2. Balkwill F Charles KA Mantovani A Smoldering and polarized inflammation in the initiation and promotion of malignant disease Cancer Cell 2005, 7:211-217. 10.1016/j.ccr.2005.02.013 15766659
3. Ben-Baruch A Inflammation-associated immune suppression in cancer: The roles played by cytokines, chemokines and additional mediators Semin Cancer Biol 2006, 16:38-52. 10.1016/j.semcancer.2005.07.006 16139507
4. De Marzo AM Marchi VL Epstein JI Nelson WG Proliferative inflammatory atrophy of the prostate: Implications for prostatic carcinogenesis Am J Pathol 1999, 155:1985-1992. 1866955 10595928
5. De Marzo AM Platz EA Sutcliffe S Xu J Gronberg H Drake CG Nakai Y Isaacs WB Nelson WG Inflammation in prostate carcinogenesis Nature Rev 2007, 7:256-269. 10.1038/nrc2090
6. Nelson WG De Marzo AM Isaacs WB Prostate cancer N Engl J Med 2003, 349:366-381. 10.1056/NEJMra021562 12878745
7. Platz EA De Marzo AM Epidemiology of inflammation and prostate cancer J Urol 2004, 171:S36-S40. 10.1097/01.ju.0000108131.43160.77 14713751
8. Dennis LK Lynch CF Torner JC Epidemiologic association between prostatitis and prostate cancer Urology 2002, 60:78-83. 10.1016/ S0090-4295(02)01637-0 12100928
9. Dennis LK Dawson DV Meta-analysis of measures of sexual activity and prostate cancer Epidemiology 2002, 13:72-79. 10.1097/ 00001648-200201000-00012 11805589
10. Oh BR Sasaki M Perinchery G Ryu SB Park YI Carroll P Dahiya R Frequent genotype changes at -308, and 488 regions of the tumor necrosis factor-alpha (TNF-alpha) gene in patients with prostate cancer J Urol 2000, 163:1584-1587. 10.1016/S0022-5347(05)67683-5 10751892
11. Wu HC Chang CH Chen HY Tsai FJ Tsai JJ Chen WC p53 gene codon 72 polymorphism but not tumor necrosis factor-alpha gene is associated with prostate cancer Urol Int 2004, 73:41-46. 10.1159/000078803 15263792
12. McCarron SL Edwards S Evans PR Gibbs R Dearnaley DP Dowe A Southgate C Easton DF Eeles RA Howell WM Influence of cytokine gene polymorphisms on the development of prostate cancer Cancer Res 2002, 62:3369-3372. 12067976
13. Danforth KN Rodriguez C Hayes RB Sakoda LC Huang WY Yu K Calle EE Jacobs EJ Chen BE Andriole GL Figueroa JD Yeager M Platz EA Michaud DS Chanock SJ Thun MJ Hsing AW TNF polymorphisms and prostate cancer risk Prostate 2008, 68:400-407. 10.1002/pros.20694 18196539
14. Lin WW Karin M A cytokine-mediated link between innate immunity, inflammation, and cancer J Clin Invest 2007, 117:1175-1183. 1857251 17476347 10.1172/JCI31537
15. Conti I Rollins BJ CCL2 (monocyte chemoattractant protein-1) and cancer Semin Cancer Biol 2004, 14:149. 10.1016/j.semcancer.2003.10.009 15246049
16. Ueno T Toi M Saji H Muta M Bando H Kuroi K Koike M Inadera H Matsushima K Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer Clin Cancer Res 2000, 6:3282. 10955814
17. Azenshtein E Luboshits G Shina S Neumark E Shahbazian D Weil M Wigler N Keydar I Ben-Baruch A The CC chemokine RANTES in breast carcinoma progression: Regulation of expression and potential mechanisms of promalignant activity Cancer Res 2002, 62:1093. 11861388
18. Antonio Sica Paola Allavena Alberto Mantovani Cancer related inflammation: The macrophage connection Cancer Leters 2008, 264:299-310. 10.1016/j.canlet.2008.01.041
19. De Marzo AM Platz EA Sutcliffe S Xu J Gronberg H Drake CG Nakai Y Isaacs WB Nelson WG Inflammation in prostate carcinogenesis Nature Rev 2007, 7:256-269. 10.1038/nrc2090
20. Hussain SP Hofseth LJ Harris CC Radical causes of cancer Nat Rev Cancer 2003, 3:276-285. 10.1038/nrc1046 12671666
21. Wilson AG Symons JA McDowell TL McDevitt HO Duff GW Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation Proc Natl Acad Sci USA 1997, 94:3195-3199. 20345 9096369 10.1073/pnas.94.7.3195
22. Mocellin S Rossi CR Pilati P Nitti D Tumor necrosis factor, cancer and anticancer therapy Cytokine Growth Factor Rev 2005, 16:35-53. 10.1016/ j.cytogfr.2004.11.001 15733831
23. Dinarello CA The interleukin-1 family: 10 years of discovery FASEB J 1994, 8:1314-1325. 8001745
24. Arend WP Interleukin 1 receptor antagonist. A new member of the interleukin 1 family J Clin Invest 1991, 88:1445-1451. 295645 1834696 10.1172/JCI115453
25. El-Omar EM Carrington M Chow WH McColl KE Bream JH Young HA Herrera J Lissowska J Yuan CC Rothman N Lanyon G Martin M Fraumeni JF Jr Rabkin CS Interleukin-1 polymorphisms associated with increased risk of gastric cancer Nature 2000, 404:398-402. 10.1038/35006081 10746728
26. Wang Y Kato N Hoshida Y Yoshida H Taniguchi H Goto T Moriyama M Otsuka M Shiina S Shiratori Y Ito Y Omata M Interleukin-1β gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection Hepatology 2003, 37:65-71. 10.1053/jhep.2003.50017 12500190
27. Zienolddiny S Ryberg D Maggini V Skaug V Canzian F Haugen A Polymorphisms of the interleukin-1β gene are associated with increased risk of non-small cell lung cancer Int J Cancer 2004, 109:353-356. 10.1002/ijc.11695 14961572
28. Landi S Moreno V Gioia-Patricola L Guino E Navarro M de Oca J Capella G Canzian F Bellvitge Colorectal Cancer Study Group Association of common polymorphisms in inflammatory genes interleukin IL6, IL8, tumor necrosis factor-a, NFK B1, andperoxisome proliferator-activated receptor g with colorectal cancer Cancer Res 2003, 63:3560-3566. 12839942
29. Grimm C Berger I Tomovski C Zeillinger R Concin N Leodolter S Koelbl H Tempfer CB Hefler LA A polymorphism of the interleukin-1 receptor antagonist plays a prominent role within the interleukin-1 gene cluster in vulvar carcinogenesis Gynecol Oncol 2004, 92:936-940. 10.1016/ j.ygyno.2003.11.039 14984963
30. Sehouli J Mustea A Koensgen D Chen FC Lichtenegger W Interleukin-1 receptor antagonist gene polymorphism is associated with increased risk of epithelial ovarian cancer Ann Oncol 2003, 14:1501-1504. 10.1093/ annonc/mdg413 14504049
31. Dominici R Cattaneo M Malferrari G Archi D Mariani C Grimaldi LM Biunno I Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha Immunogenetics 2002, 54:82-6. 10.1007/s00251-002-0445-9 12037600
32. Mulé JJ Custer M Averbook B Yang JC Weber JS Goeddel DV Rosenberg SA Schall TJ RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: Role of immune cell subpopulations Hum Gene Ther 1996, 7:1545-1553. 10.1089/hum.1996.7.13-1545 8864755
33. Duell EJ Casella DP Burk RD Kelsey KT Holly EA Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma Cancer Epidemiol Biomarkers Prev 2006, 4:726-731. 10.1158/1055-9965.EPI-05-0797
34. Yoshimura T Robinson EA Tanaka S Appella E Kuratsu J Leonard EJ Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants J Exp Med 1989, 169:1449-1459. 2189237 2926329 10.1084/jem.169.4.1449
35. Roth SJ Carr MW Springer TA C-C chemokines, but not the C-X-C chemokines interleukin-8 and interferon-γ inducible protein-10, stimulate transendothelial chemotaxis of T lymphocytes Eur J Immunol 1995, 25:3482-488. 10.1002/eji.1830251241 8566041
36. Ghilardi G Biondi ML La Torre A Battaglioli L Scorza R Breast cancer progression and host polymorphisms in the chemokine system: Role of the macrophage chemoattractant protein-1 (MCP-1) -2518 G allele Clin Chem 2005, 51:452-455. 10.1373/clinchem.2004.041657 15681563
37. Saji H Koike M Yamori T Saji S Seiki M Matsushima K Toi M Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma Cancer 2001, 92:1085-1091. 10.1002/ 1097-0142(20010901)92:5<1085::AID-CNCR1424>3.0.CO;2-K 11571719
38. Liu H Chao D Nakayama EE Taguchi H Goto M Xin X Takamatsu JK Saito H Ishikawa Y Akaza T Juji T Takebe Y Ohishi T Fukutake K Maruyama Y Yashiki S Sonoda S Nakamura T Nagai Y Iwamoto A Shioda T Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression Proc Natl Acad Sci USA 1999, 96:4581-4585. 16375 10200305 10.1073/pnas.96.8.4581
39. Rovin BH Lu L Saxena R A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression Biochem Biophys Res Commun 1999, 259:344-348. 10.1006/bbrc.1999.0796 10362511
40. Wilson AG Symons JA McDowell TL McDevitt HO Duff GW Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation Proc Natl Acad Sci USA 1997, 94:3195-3199. 20345 9096369 10.1073/pnas.94.7.3195
41. Fraile A Nieto A Beraún Y Vinasco J Matarán L Martín J Tumor necrosis factor gene polymorphisms in ankylosing spondylitis Tissue Antigens 1998, 51:386-390. 9583811
42. Nearman ZP Wlodarski M Jankowska AM Howe E Narvaez Y Ball E Macijewski JP Immunogenetic factors determining the evolution of T-cell large granular lymphocyte leukaemia and associated cytopenias Br J Haematol 2007, 136:237-248. 10.1111/j.1365-2141.2006.06429.x 17156396
43. Ho SY Wang YJ Huang PC Tsai ST Chen CH Chen HH Chang CJ Guo HR Evaluation of the associations between the single nucleotide polymorphisms of the promoter region of the tumor necrosis factor-alpha gene and nasopharyngeal carcinoma J Chin Med Assoc 2006, 69:351-357. 16970270
44. Govan VA Constant D Hoffman M Williamson AL The allelic distribution of -308 Tumor Necrosis Factor-alpha gene polymorphism in South African women with cervical cancer and control women BMC Cancer 2006, 26:24. 10.1186/1471-2407-6-24
45. Gelmann EP Complexities of prostate-cancer risk N Engl J Med 2008, 358:961-3. 10.1056/NEJMe0708703 18199856
46. Oliver J Gómez-García M Paco L López-Nevot MA Piñero A Correro F Martín L Brieva JA Nieto A Martín J A functional polymorphism of the NFKB1 promoter is not associated with ulcerative colitis in a Spanish population Inflamm Bowel Dis 2005, 11:576-9. 10.1097/01.MIB.0000161916.20007.76 15905705
47. Sun J Wiklund F Zheng SL Chang B Bälter K Li L Johansson JE Li G Adami HO Liu W Tolin A Turner AR Meyers DA Isaacs WB Xu J Grönberg H Sequence variants in Toll-like receptor gene cluster (TLR6 -TLR1-TLR10) and prostate cancer risk J Natl Cancer Inst 2005, 97:525-532. 15812078
48. Zheng SL Augustsson-Bälter K Chang B Hedelin M Li L Adami HO Bensen J Li G Johnasson JE Turner AR Adams TS Meyers DA Isaacs WB Xu J Grönberg H Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: Results from the Cancer Prostate in Sweden Study Cancer Res 2004, 64:2918-2922. 10.1158/0008-5472.CAN-03-3280 15087412
49. El-Omar EM Carrington M Chow WH McColl KE Bream JH Young HA Herrera J Lissowska J Yuan CC Rothman N Lanyon G Martin M Fraumeni JF Jr Rabkin CS Interleukin-1 polymorphisms associated with increased risk of gastric cancer Nature 2000, 404:398-402. 10.1038/35006081 10746728
50. Hefler LA Ludwig E Lebrecht A Zeillinger R Tong-Cacsire D Koelbl H Leodolter S Tempfer CB Polymorphisms of the interleukin-1 gene cluster and ovarian cancer J Soc Gynecol Investig 2002, 9:386-90. 10.1016/ S1071-5576(02)00177-6 12445604
51. Hefler LA Grimm C Lantzsch T Lampe D Leodolter S Koelbl H Heinze G Reinthaller A Tong-Cacsire D Tempfer C Zeillinger R Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in caucasian women Clin Cancer Res 2005, 11:5718-21. 10.1158/ 1078-0432.CCR-05-0001 16115908
52. Kamangar F Cheng C Abnet CC Rabkin CS Interleukin-1B polymorphisms and gastric cancer risk-a meta-analysis Cancer Epidemiol Biomarkers 2006, 15:1920-8. 10.1158/1055-9965.EPI-06-0267
53. Mule JJ Custer M Averbook B Rantes secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: Role of immune cell subpopulations Hum Gene Ther 1996, 7:1545-53. 10.1089/hum.1996.7.13-1545 8864755
54. Sánchez E Sabio JM Callejas JL de Ramón E Garcia-Portales R García-Hernández FJ Jiménez-Alonso J González-Escribano MF Martín J Koeleman BP Association study of genetic variants of pro-inflammatory chemokine and cytokine genes in systemic lupus erythematosus BMC Med Genet 2006, 7:48. 1488833 16719905 10.1186/1471-2350-7-48
55. Vinasco J Beraún Y Nieto A Fraile A Mataran L Pareja E Martín J Polymorphism at the TNF loci in rheumatoid arthritis Tissue Antigens 1997, 49:74-8. 10.1111/j.1399-0039.1997.tb02715.x 9027971
56. Lio D Scola L Crivello A Colonna-Romano G Candore G Bonafé M Cavallone L Marchegiani F Olivieri F Franceschi C Caruso C Inflammation, genetics, and longevity: Further studies on the protective effects in men of IL-10 -1082 promoter SNP and its interaction with TNF-alpha -308 promoter SNP J Med Genet 2003, 40:296-9. 1735442 12676903 10.1136/ jmg.40.4.296
57. Cardelli M Cavallone L Marchegiani F Oliveri F Dato S Montesanto A Lescai F Lisa R De Benedictis G Franceschi C A genetic-demographic approach reveals male-specific association between survival and tumor necrosis factor (A/G)-308 polymorphism J Gerontol A Biol Sci Med Sci 2008, 63:454-60. 18511747